Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Classifying the structural heterogeneity of peritoneal adhesions by histopathological extracellular matrix characteristics.

Langenbeck's archives of surgery·2026
Same author

Mutation enrichment in targeted panels flags immunotherapy-responsive POLE-driven hypermutated microsatellite-stable colorectal cancers.

NPJ precision oncology·2026
Same author

Energy Balance-Related Factors and Direct Tumor-Adipocyte Contact in Colorectal Cancer: Etiology Insights from the Population-Based Netherlands Cohort Study.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same author

SCRIPT: Stratified clinical risk prediction from pathology reports using large language models.

Journal of pathology informatics·2026
Same author

Spatial dissection of ADC/RPT targets defines heterogeneous expression landscapes and therapeutic implications in rhabdoid tumors.

Neuro-oncology·2026
Same author

HISTAI: a valuable dataset with a valuable lesson.

The journal of pathology. Clinical research·2026

相关实验视频

Updated: Jun 11, 2025

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.6K

[SARIFA-一个新的多实体生物标志物]

Bianca Grosser1, Nic G Reitsam1, Przmyslaw Grochowski1

  • 1Institut für Pathologie und Molekulare Diagnostik, Medizinische Fakultät Augsburg, Universitätsklinikum Augsburg, Stenglinstraße 2, 86156, Augsburg, Deutschland.

Pathologie (Heidelberg, Germany)
|October 4, 2024
PubMed
概括

一个新的预后生物标志物,斯特罗玛a-反应性入侵前部区域 (SARIFA),识别瘤细胞和脂肪细胞接触. 这种易于识别的特征显示了多种癌症类型的预后价值.

关键词:
脂肪细胞是一种脂肪细胞.癌瘤的癌症是什么结直肠瘤是什么意思历史学 历史学 历史学预测 预测 预测 预测

更多相关视频

Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples
13:21

Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples

Published on: May 4, 2012

15.7K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.4K

相关实验视频

Last Updated: Jun 11, 2025

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.6K
Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples
13:21

Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples

Published on: May 4, 2012

15.7K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.4K

科学领域:

  • 在瘤学瘤学.
  • 病理学 病理学 病理学
  • 癌症生物标志物 癌症生物标志物

背景情况:

  • 确定可靠的预后生物标志物对于有效的癌症患者管理至关重要.
  • 现有的生物标志物可能需要复杂的分析或额外的染色,限制广泛的临床应用.

研究的目的:

  • 为了引入和验证一个新的预后生物标志物,Stroma a-reactive入侵前面区域 (SARIFA).
  • 评估SARIFA在各种癌症类型中的预后效率.

主要方法:

  • SARIFA被定义为至少五个瘤细胞与脂肪细胞之间的直接接触.
  • 标识是在标准的血素和氨酸 (HE) 染色组织部分上进行的.
  • 评估观察者之间的变化和易于识别.

主要成果:

  • SARIFA的特点是其简单和快速的识别.
  • 该生物标志物表现出极低的观察者间变异性.
  • 在胃癌,结肠直肠癌,胰腺癌和前列腺癌中证实了SARIFA的预后效率.

结论:

  • 斯特罗玛a-反应性入侵前面区域 (SARIFA) 是一种新的,易于识别的预后生物标志物.
  • 在一系列常见的癌症中,SARIFA具有显著的预后价值.
  • 它在标准HE段上的实用性使其成为常规病理学的实用工具.